Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry.

Subjects: Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/drug therapy ; COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Oct 21; Vol. 83 (11), pp. 1584-1595. Date of Electronic Publication: 2024 Oct 21.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic)

Record details

×
Academic Journal

Identifying the association between serum urate levels and gout flares in patients taking urate-lowering therapy: a post hoc cohort analysis of the CARES trial with consideration of dropout.

Subjects: Gout*/Gout*/Gout*/blood ; Gout*/Gout*/Gout*/drug therapy ; Gout Suppressants*/Gout Suppressants*/Gout Suppressants*/therapeutic use

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Sep 30; Vol. 83 (10), pp. 1375-1380. Date of Electronic Publication: 2024 Sep 30.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic)

Record details

×
Academic Journal

Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination.

  • Authors : Lu J; Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, the Affiliated Hospital of Qingdao University, Qingdao, China.; Shandong Provincial Clinical Research Center for Immune Diseases and Gout, the Affiliated Hospital of Qingdao University, Qingdao, China.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; Colchicine*/Colchicine*/Colchicine*/therapeutic use

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2022 Aug; Vol. 81 (8), pp. 1189-1193. Date of Electronic Publication: 2022 Mar 11.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060

Record details

×
Academic Journal

Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong.

  • Authors : Li X; Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Subjects: Symptom Flare Up*; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*chemically induced ; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*adverse effects

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2022 Apr; Vol. 81 (4), pp. 564-568. Date of Electronic Publication: 2021 Oct 22.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060

Record details

×
Academic Journal

Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.

  • Authors : Almeida-Brasil CC; Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.; Hanly JG

Subjects: Symptom Flare Up*; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*administration & dosage ; Drug Tapering/Drug Tapering/Drug Tapering/*statistics & numerical data

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2022 Mar; Vol. 81 (3), pp. 370-378. Date of Electronic Publication: 2021 Dec 15.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060

Record details

×
Editorial & Opinion

Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City.

  • Authors : Barbhaiya M; Division of Rheumatology, Hospital for Special Surgery, New York, New York, USA .; Department of Medicine and Department of Population Health Sciences, Weill Cornell Medicine, New York, New York, USA.

Subjects: Rheumatic Diseases* ; Symptom Flare Up*; COVID-19/COVID-19/COVID-19/*prevention & control

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Oct; Vol. 80 (10), pp. 1352-1354. Date of Electronic Publication: 2021 Jun 22.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060

Record details

×
Academic Journal

Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort.

Subjects: COVID-19* ; Symptom Flare Up*; Arthritis, Psoriatic/Arthritis, Psoriatic/Arthritis, Psoriatic/*physiopathology

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Feb; Vol. 80 (2), pp. 238-241. Date of Electronic Publication: 2020 Sep 22.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060

Record details

×
Academic Journal

Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study.

  • Authors : Emery P; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK .; NIHR Leeds Biomedical Research Centre, Leeds, UK.

Subjects: Symptom Flare Up*; Adalimumab/Adalimumab/Adalimumab/*administration & dosage ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*administration & dosage

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2020 Aug; Vol. 79 (8), pp. 1023-1030. Date of Electronic Publication: 2020 May 13.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060

Record details

×
Academic Journal

An induction or flare of arthritis and/or sacroiliitis by vedolizumab in inflammatory bowel disease: a case series.

  • Authors : Varkas G; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.; VIB Inflammation Research Center, Ghent University, Ghent, Belgium.

Subjects: Symptom Flare Up*; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*adverse effects ; Gastrointestinal Agents/Gastrointestinal Agents/Gastrointestinal Agents/*adverse effects

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2017 May; Vol. 76 (5), pp. 878-881. Date of Electronic Publication: 2016 Nov 29.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060

Record details

×
  • 1-10 of  51 results for ""Symptom Flare Up""